Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    alps, niaid | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Condition: Autoimmune Lymphproliferative Syndrome
Intervention:
2 Not yet recruiting Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: Bivalent Subtype C gp120/MF59 vaccine;   Biological: Bivalent Subtype C gp120/AS01B vaccine;   Biological: Placebo

Study has passed its completion date and status has not been verified in more than two years.